Skip to main content

Table 4 Univariate analysis for progression free survival

From: Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma

Variables

N

Progression free survival (months)

P

Median ± SE

95% CI

CypA

   

<0.01

     Low

16

16.42 ± 1.16

17.08-21.76

 

     High

54

7.42 ± 0.60

6.24-8.59

 

MMP9

   

<0.01

     Low

20

16.332 ± 1.75

10.91-14.93

 

     High

50

7.70 ± 0.62

6.49-8.91

 

Age

   

0.220

     <65

48

11.47 ± 1.22

9.08-13.87

 

     ≥65

22

9.44 ± 1.23

7.03-11.84

 

Gender

   

0.950

     Male

45

10.82 ± 1.24

8.38-13.25

 

     Female

25

11.30 ± 1.45

8.46-14.15

 

Smoking

   

0.269

     Yes (>40 pack-years)

51

10.06 ± 1.02

8.01-12.05

 

     No

19

12.35 ± 1.82

8.79-15.92

 

Drink

   

0.406

     Yes (>50 ml/day)

39

11.28 ± 1.25

8.83-13.72

 

     No

31

10.07 ± 11.32

7.48-12.66

 

Differentiation

   

<0.01

     Well + Moderate

39

13.33 ± 1.28

10.82-15.84

 

     Poor

31

7.07 ± 0.78

5.54-8.60

 

TNM stage

   

0.295

     I–II

22

12.02 ± 1.87

8.36-15.67

 

     III–IV

48

10.20 ± 1.02

8.20-12.19

 

Lymph node

   

0.041

     Metastasis

38

8.79 ± 1.20

6.44-11.14

 

     No metastasis

32

12.75 ± 1.20

10.40-15.10